Endpoints for relative effectiveness assessment (REA) of pharmaceuticals
The aim of this article is to describe the guideline development process and the key findings that set a framework for appropriate use of endpoints in relative effectiveness assessment (REAs) in Europe.
This Academic Publication is available from
Date of publication:
06 Mar 2015
Authors:
Pavlovic M, Teljeur C, Wieseler B, Klemp M, Cleemput I & Neyt M. Endpoints for relative effectiveness assessment (REA) of pharmaceuticals. International Journal of Technology Assessment in Health Care. 2014;30(5):508-13.
Journal:
International Journal of Technology Assessment in Health Care
Digital object identifier:
DOI: 10.1017/S0266462314000592
Type of output:
Original Research
Suggested Citation:
Pavlovic M, Teljeur C, Wieseler B, Klemp M, Cleemput I & Neyt M. Endpoints for relative effectiveness assessment (REA) of pharmaceuticals. International Journal of Technology Assessment in Health Care. 2014;30(5):508-13.